Skip to main content
. Author manuscript; available in PMC: 2023 Mar 17.
Published in final edited form as: Cell Chem Biol. 2021 Nov 29;29(3):517–529.e5. doi: 10.1016/j.chembiol.2021.11.005

Table 1.

Cell cycle proteins specifically downregulated by p97 inhibitors.

Description Gene name Log2FC
Cell cycle
6h 24h

MG132 CB-5083 NMS-873 MG132 CB-5083 NMS-873

Securin PTTG1 1.4 −0.9 −1.2 −0.1 −1.9 −2.9 M
G1/S-specific cyclin-D1 CCND1 0.2 −1.4 −1.8 0.4 −2.0 −3.2 G1/S
Myc proto-oncogene protein MYC 1.2 −0.5 −1.1 0.2 −0.7 −1.1 G1/S
Baculoviral IAP repeat-containing protein 5 BIRC5 0.6 −0.5 −0.5 1.0 −0.8 −2.0 M/check point
F-box only protein 5 FBXO5 0.2 −0.8 −1.1 1.5 −1.0 −2.4 M/G1
Cell division cycle protein 20 homolog CDC20 0.8 −0.4 −0.6 1.1 −1.5 −2.8 M/check point
Mitotic checkpoint serine/threonine-protein kinase BUB1 BUB1 1.2 −0.3 −0.4 1.4 −1.1 −2.1 M/check point
M-phase inducer phosphatase 2 CDC25B 0.3 −1.1 −1.6 −0.2 −1.6 −2.2 S/G2/M
Origin recognition complex subunit 6 ORC6 0.3 −0.4 −0.5 1.0 −0.3 −0.6 G1/S/ch eckpoint
Geminin GMNN 0.9 −0.4 −0.6 1.4 −1.1 −1.8 G1/S
Ribonucleoside-diphosphate reductase subunit M2 RRM2 0.6 −0.2 −0.3 1.2 −1.1 −2.7 G1

TMT label proteomic results for 6h and 24h treatment. Log2FC indicates log2 fold change (compound vs DMSO). BH adjusted p-values with FDR less than 0.05 see Table S4.